Development of the multiple metabolic syndrome in the ARIC cohort: Joint contribution of insulin, BMI, and WHR

Annals of Epidemiology

Volumn 7, Issue 6, 1997, Pages 407-416

  Liese, Angela D ^a   Mayer Davis, Elizabeth J ^b   Tyroler, Herman A ^c   Davis, C E ^c   Keil, Ulrich ^a   Duncan, Bruce B ^d   Heiss, Gerardo ^c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Diabetes Mellitus; Hypertension; Insulin; Insulin Resistance; Lipoproteins.; Non insulin dependent; Obesity

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN; LOGISTIC MODELS; MALE; METABOLIC DISEASES; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; SYNDROME; UNITED STATES;

EID: 0030844241     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(97)00047-1     Document Type: Article

References (46)

1. Criqui MH, Cowan LD, Heiss G, Haskell WL, Laskarzewski PM, Chambless LE. Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study. Circulation. 1986;73:140-150.
2. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416-422.
3. Jousilahti P, Tuomilehto J, Korhonen HJ, Vartiainen E, Puska P, Nissinen A. Trends in cardiovascular disease risk factor clustering in eastern Finland: results of 15-year follow-up of the North Karelia project. Prev Med. 1994;23:6-14.
4. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41:715-722.
5. Kesäniemi YA, Lilja M, Kervinen K, Rantala A. Multiple metabolic syndrome: aspects of genetic epidemiology and molecular genetics. Ann Med. 1992;24:461-464.
6. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
7. Schmidt MI, Duncan BB, Watson RL, et al. A metabolic syndrome in Whites and African Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care. 1996;19:414-418.
8. Carroll M, Sempos C, Briefel R, Gray S, Johnson C. Serum lipids of adults 20-74 years: United States, 1976-80. Vital Health Stat. 1993:(Series 11):1-107.
9. Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149: 1514-1520.
10. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956;4:20-34.
11. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14: 173-194.
12. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes. 1990;39:283-288.
13. Mykkänen L, Kuusisto J, Haffner SM, Pyörälä K, Laakso M. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thromb. 1994;14:518-526
14. Mykkänen L, Kuusisto J, Haffner S, Pyörälä K, Laakso M. Fasting plasma insulin in relation to the development of hypertension in elderly subjects (abstract). Circulation. 1994;90:1665.
15. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991 JAMA. 1994;272: 205-211.
16. Pietinen P, Vartiainen E, Männistö S. Trends in body mass index and obesity among adults in Finland from 1972 to 1992. Int J Obes Relat Metab Disord. 1996;20:114-120.
17. Prentice AM, Jebb SA. Obesity in Britain: gluttony or sloth? BMJ. 1995;311:437-439.
18. Hara H, Egusa G, Yamakido M, Kawate R. The high prevalence of diabetes mellitus and hyperinsulinemia among the Japanese-Americans living in Hawaii and Los Angeles. Diabetes Res Clin Pract. 1994; 24:S37-S42.
19. Lindahl B, Asplund K, Hallmans G. High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The northern Sweden MONICA population study. J Intern Med. 1993;234: 263-270.
20. Després J-P. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition. 1993;9:452-459.
21. Selby JV, Austin MA, Newman B, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 1993; 88:381-387.
22. Jackson R, Chambless LE, Yang K, et al. Differences between respondents and nonrespondents in a multi-center community-based study vary by gender and ethnicity. J Clin Epidemiol. 1996;46:1441-1446.
23. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989; 129: 687-702.
24. National Heart, Lung, and Blood Institute. ARIC protocol (1987). Manual 2,7,10,11. ARIC Coordinating Center, School of Public Health, University of North Carolina, Chapel Hill.
25. World Health Organization. WHO Expert Committee on Diabetes Mellitus: 2nd report. Geneva, Switzerland: World Health Organization; 1980.
26. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA. 1993;269:3015-3023.
28. Burchfiel CM, Curb JD, Rodriguez BL, et al. Incidence and predictors of diabetes in Japanese-American men. The Honolulu Heart Program. Ann Epidemiol. 1995;5:33-43.
29. Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus. A prospective cohort study of men in the Normative Aging Study. Am J Epidemiol. 1992;136:1474-1486.
30. Hanson RL, Narayan KMV, McCance DR, et al. Rate of weight gain, weight fluctuation, and incidence of NIDDM. Diabetes. 1995;44: 261-266.
31. Knowler WC, Pettitt DJ, Saad MF, et al. Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr. 1991; 53:15435-15518.
32. Ohlson L-O, Larsson B, Svärdsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985;34:1055-1058.
33. Charles MA, Fontbonne A, Thibult N, Warnet J-M, Rosselin GE, Eschwege E. Risk factors for NIDDM in white population. Paris Prospective Study. Diabetes. 1991;40:796-799.
34. Knowler WC, Pettitt DJ, Saad MF, Bennett PH. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev. 1990;6:1-27.
35. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia. 1993;36:553-559.
36. Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension. 1992;20:38-45.
37. Haffner SM, Mykkänen L, Valdez RA, Stern MP. Evaluation of two insulin assays in insulin resistance syndrome (syndrome X). Arterioscler Thromb. 1994;14:1430-1437.
38. Haffner SM, Mykkänen L, Valdez RA, et al. Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab. 1994;79:1806-1810.
39. Flegal KM, Keyl PM, Nieto FJ. Differential misclassification arising from nondifferential errors in exposure measurement. Am J Epidemiol. 1991;134:1233-1244.
40. Nieto FJ, Alonso J, Chambless LE, et al. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities Study. Arch Intern Med. 1995;155:677-684.
41. Davis CE. Regression to the mean. In: Kotz S. Johnson NL, Read CB, eds. Encyclopedia of Statistical Sciences. New York: John Wiley & Sons; 1986;706-708.
42. Eckfeldt JH, Chambless LE, Shen Y-L for the ARIC Investigators. Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. Arch Pathol Lab Med. 1994;118:496-500.
43. Chambless LE, McMahon RP, Brown SA, Patsch W, Heiss G, Shen Y-L. Short-term intraindividual variability in lipoprotein measurements: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1992;136:1069-1981.
44. Shepard DS. Reliability of blood pressure measurements: implications for designing and evaluating programs to control hypertension. J Chronic Dis. 1981;34:191-209.
45. National Institutes of Health Consensus Development Panel on the Health Implications of Obesity. Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Ann Intern Med. 1985;103:1073-1077.
46. Rose G. High-risk and population strategies of prevention: ethical considerations, Ann Med. 1989;21:409-413.